Immediate Impact
9 standout
Citing Papers
PSMA-PET/CT Findings in Patients With High-Risk Biochemically Recurrent Prostate Cancer With No Metastatic Disease by Conventional Imaging
2025 Standout
Revolutionizing prostate cancer therapy: Artificial intelligence – Based nanocarriers for precision diagnosis and treatment
2025 Standout
Works of William Yaxley being referenced
Primary tumour PSMA intensity is an independent prognostic biomarker for biochemical recurrence-free survival following radical prostatectomy
2022
Histological comparison between predictive value of preoperative 3‐T multiparametric MRI and 68 Ga‐PSMA PET/CT scan for pathological outcomes at radical prostatectomy and pelvic lymph node dissection for prostate cancer
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| William Yaxley | 204 | 65 | 19 | 66 | 19 | 246 | |
| Igor Nunes‐Silva | 243 | 83 | 31 | 37 | 27 | 279 | |
| Amer Amin | 171 | 55 | 11 | 47 | 15 | 223 | |
| Arnas Rakauskas | 256 | 101 | 14 | 62 | 18 | 286 | |
| Alex Kirkham | 253 | 93 | 17 | 107 | 20 | 271 | |
| Shivaram Cumarasamy | 244 | 82 | 22 | 41 | 23 | 279 | |
| Oğuz Özden Cebeci | 116 | 46 | 72 | 49 | 15 | 216 | |
| Peter-Paul Willemse | 172 | 54 | 11 | 39 | 19 | 258 | |
| Elise De Bleser | 177 | 40 | 27 | 63 | 17 | 229 | |
| Alessandro Marquis | 152 | 53 | 34 | 28 | 28 | 178 | |
| Ben Eddy | 241 | 86 | 24 | 66 | 14 | 279 |
All Works
Login with ORCID to disown or claim papers
Loading papers...